PYPL
56
-6
FOX
59
2
MSI
76
-3
AMAT
46
3
NTRS
55
-5
PCAR
62
-2
KSS
46
4
COP
59
2
TEL
69
-5
PNR
71
-3
XRAY
23
3
VTR
50
-5
CHRW
65
-2
HUM
46
-2
XRX
37
3
GE
65
-6
IR
68
-3
FLR
50
2
EL
20
2
BMY
63
2
PYPL
56
-6
FOX
59
2
MSI
76
-3
AMAT
46
3
NTRS
55
-5
PCAR
62
-2
KSS
46
4
COP
59
2
TEL
69
-5
PNR
71
-3
XRAY
23
3
VTR
50
-5
CHRW
65
-2
HUM
46
-2
XRX
37
3
GE
65
-6
IR
68
-3
FLR
50
2
EL
20
2
BMY
63
2
Financhill
Back

Evoke Pharma 10K Form

Sell
17

EVOK
Evoke Pharma

Last Price:
4.56
Seasonality Move:
12.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14 10Q EVOK/Evoke Pharma Quarterly
2023-11-09 10Q EVOK/Evoke Pharma Quarterly
2023-08-10 10Q EVOK/Evoke Pharma Quarterly
2023-05-15 10Q EVOK/Evoke Pharma Quarterly
2022-11-09 10Q EVOK/Evoke Pharma Quarterly
2022-08-10 10Q EVOK/Evoke Pharma Quarterly

Receive EVOK News And Ratings

See the #1 stock for the next 7 days that we like better than EVOK

EVOK Financial Statistics

Sales & Book Value

Annual Sales: $5.18M
Cash Flow: $-818.7K
Price / Cash Flow: 0
Annual Sales: $4.90
Price / Book: 1.48

Profitability

EPS (TTM): -11.03000
Net Income (TTM): $-6.15M
Gross Margin: $4.98M
Return on Equity: -433.12%
Return on Assets: -57.27%

Evoke Pharma Earnings Forecast

Key Evoke Pharma Financial Ratios

  • The Gross Profit Margin over the past 13 years for EVOK is 96.10%.
  • The Selling, General & Administrative Expenses for EVOK have been equal to 236.03% of Gross Profit Margin.
  • The Research & Development expenses have been 3.51% of Revenue.
  • The Interest Expense is -6.42% of Operating Income.
  • The Net Earning history of EVOK is -150.41% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 10 years.

Evoke Pharma Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: EVOK
CUSIP: 30049G
Website: evokepharma.com

Debt

Debt-to-Equity Ratio: 1.14
Current Ratio: 1.44
Quick Ratio: 1.37

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 9.1

EVOK Technical Analysis vs Fundamental Analysis

Sell
17
Evoke Pharma (EVOK) is a Sell

Is Evoke Pharma a Buy or a Sell?

  • Evoke Pharma stock is rated a Sell
    The current Evoke Pharma [EVOK] share price is $4.37. The Score for EVOK is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.